Goldman Sachs Group Inc Immatics N.V. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Immatics N.V. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,380,406 shares of IMTX stock, worth $12.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,380,406
Previous 114,265
1983.23%
Holding current value
$12.1 Million
Previous $1.3 Million
1198.85%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding IMTX
# of Institutions
98Shares Held
78.3MCall Options Held
238KPut Options Held
727K-
Wellington Management Group LLP Boston, MA10.4MShares$52.8 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY10MShares$50.7 Million1.82% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$41 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.38MShares$37.4 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$32.7 Million0.79% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $386M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...